Preparation of nanoliposomes linked to HER2/neu‐derived (P5) peptide containing MPL adjuvant as vaccine against breast cancer-Reference-Cited by-同舟云学术

Preparation of nanoliposomes linked to HER2/neu‐derived (P5) peptide containing MPL adjuvant as vaccine against breast cancer

Published:2018-10-30 Issue:2 Volume:120 Page:1294-1303
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Rastakhiz Saeedeh¹²,Yazdani Mona¹,Shariat Sheida³,Arab Atefeh⁴,Momtazi‐Borojeni Amir Abbas⁵^ORCID,Barati Nastaran⁴,Mansourian Mercedeh¹⁶²,Amin Mohamdreza⁷⁸,Abbasi Azam¹,Saberi Zahra¹,Jalali Seyed Amir⁹,Badiee Ali¹⁶²,Jaafari Mahmoud Reza¹⁶²^ORCID

Affiliation:

1. Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences Mashhad Iran

2. Department of Pharmaceutical Nanotechnology School of Pharmacy Mashhad University of Medical Science Mashhad Iran

3. School of pharmacy Shahid Beheshti University of Medical Science Tehran Iran

4. Department of Pharmaceutical Biotechnology School of Pharmacy Mashhad University of Medical Sciences Mashhad Iran

5. Nanotechnology Research Center, Department of Medical Biotechnology Student Research Committee, School of Medicine, Mashhad University of Medical Sciences Mashhad Iran

6. Biotechnology Research Center Pharmaceutical Technology Institute Mashhad University of Medical Sciences Mashhad Iran

7. Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center Rotterdam The Netherlands

8. Cellular and Molecular Research Center, Faculty of Medicine, Sabzevar University of Medical Sciences Sabzevar Iran

9. Department of Immunology Faculty of Medicine, Shahid Beheshti University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.27090

Reference47 articles.

1. Liposomes as vaccine delivery systems: a review of the recent advances

2. Enhancement of immune response and protection in BALB/c mice immunized with liposomal recombinant major surface glycoprotein of Leishmania (rgp63): The role of bilayer composition

3. Liposome-mediated DNA vaccination: the effect of vesicle composition

4. Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens

5. Immunogenicity of liposomal model membranes in mice: dependence on phospholipid composition.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in liposome-based targeted cancer therapy;Journal of Liposome Research;2023-10-09

2. Improving the efficacy of peptide vaccines in cancer immunotherapy;International Immunopharmacology;2023-10

3. Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine;Scientific Reports;2023-04-10

4. Nanomaterials in Cancer Immunotherapy: A Spotlight on Breast Cancer;Science of Advanced Materials;2023-03-01

5. Self-assembled nanoparticles: A new platform for revolutionizing therapeutic cancer vaccines;Frontiers in Immunology;2023-02-21